Health system performance assessment
Understanding how health systems work, what barriers exist to the proper implementation of health policy,
and how external and institutional factors can affect the ability of the health system
to respond to routine and extraordinary health threats.
Analysis of health system inputs 保健医療制度のインプット分析
To understand how health system financing, human resource distribution and planning,
or private organizations and individuals can work to improve health system performance.
Analysis of health system outputs 保健医療制度のアウトプット分析
To examine how health systems perform, how well they deliver the services they are funded for,
and how policy-making is converted into practice in the real world. Understanding how resource allocation can affect and be affected by disease and illness.
Measuring impact インパクトの測定
To estimate the magnitude of a policy’s effect and the effectiveness of a health system or policy change in measurable
and important health outcomes, including tracking progress towards the Millennium Development Goals and contributing to the Global Burden of Disease study.
Shimizu K, Gilmour S, Mase H, Le PM, Teshima A, Sakamoto H, Nomura S. COVID-19 and Heat Illness in Tokyo, Japan: Implications for the Summer Olympic and Paralympic Games in 2021. Int J Environ Res Public Health. 2021 Mar 31;18(7):3620.
Makiyama K, Kawashima T, Nomura S, Eguchi A, Yoneoka D, Tanoue Y, Kawamura Y, Sakamoto H, Gilmour S, Shi S, Matsuura K, Uryu S, Hashizume M. Trends in Healthcare Access in Japan during the first wave of the COVID-19 pandemic, up to June 2020. Int J Environ Res Public Health. 2021 Mar 22;18(6):3271.
Yoneoka D, Shi S, Nomura S, Tanoue Y, Kawashima T, Eguchi A, Matsuura K, Makiyama K, Uryu S, Ejima K, Sakamoto H, Taniguchi T, Kunishima H, Gilmour S, Nishiura H, Miyata H. Assessing the regional impact of Japan's COVID-19 state of emergency declaration: a population-level observational study using social networking services. BMJ Open. 2021 Feb 15;11(2):e042002.
Nomura S, Yoneoka D, Tanaka S, Makunouchi R, Sakamoto H , Ishizuka A, Nakamura H, Kubota A, Shibuya K. Limited alignment of publicly competitive disease funding with disease burden in Japan. PLoS ONE. 2020 Feb 10.
Nakamura H, Amimo F, Yi S, Tuot S, Yoshida T, Tobe M, Nomura S. Implementing a sustainable health insurance system in Cambodia: a study protocol for developing and validating an efficient household income-level assessment model for equitable premium collection. Int J Equity Health. 2020 Jan 31;19(1):172020; 15(1): E0227565.
Rahman MMa, Zhang C, Swe KT, Rahman MS, Islam MR, Kamrujjaman M, Sultana P, Hassan MZ, Alam MS, Rahman MM. Disease-specific out-of-pocket healthcare expenditure in urban Bangladesh: A Bayesian analysis. PLoS ONE. 2020; 15(1): E0227565.
Zhang C, Rahman MS, Rahman MM, Yawson AE, , Shibuya K. Trends and projections of universal health coverage indicators in Ghana, 1995-2030: a national and subnational study. PLoS ONE. 2019; 14(5): e0209126.
Sakamoto H , Ghaznavi C, Shibuya K, . Country Chapter 7 - Japan . In Legido-Quigley H, Asgari-Jirhandeh N, editors. Resilient and people-centred health systems: Progress, challenges and future directions in Asia. New Delhi: World Health Organization, Regional Office for South-East Asia, 2018.
Nomura S, Shibuya K. Improving Population Health in the Era of Superaging: Japan’s Challenges and Opportunities. In: Sean Connell, Shuhei Nomura, Kenji Shibuya and Benjamin Shobert. Innovative Asia: Innovation Policy and the Implications for Healthcare and the Life Sciences. Washington: The National Bureau of Asian Research; 2018.
Rahman MS, Rahman MM, Gilmour S, Swe KT, Abe SK, Shibuya K. Trends in, and projections of, indicators of universal health coverage in Bangladesh, 1995–2030: a Bayesian analysis of population-based household data. The Lancet Global Health. 2018; 6: e84-94.
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1345-1422.
GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1260–1344.
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1151–1210.
GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390: 1084–1150.